News

GNCA

Genocea Biosciences (GNCA): Positive Top Line Data for Genital Herpes Drug

Edward Kim | Equities.com |

Genocea Biosciences reported positive top line Phase 2b data on its genital herpes treatment.


Genocea Biosciences Inc. (GNCA) Drops 5.93% on November 03

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) was one of the Russell 2000's biggest losers for Thursday November 03 as the stock slid 5.93% to $3.33, a loss of $-0.21 per share. Starting at an opening price of


Genocea Biosciences Inc. (GNCA) Jumps 12% on October 13

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) was among the biggest gainers on the Russell 2000 for Thursday October 13 as the stock popped 12% to $4.20, representing a gain of $0.45 per share. Some 492,519


Genocea Biosciences Inc. (GNCA) Drops 5.3% on October 12

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) was one of the Russell 2000's biggest losers for Wednesday October 12 as the stock slid 5.3% to $3.75, a loss of $-0.21 per share. Starting at an opening price of


Genocea Biosciences Inc. (GNCA) is Trading Lower on Unusual Volume for October 04

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) experienced unusually high volume on Oct. 04, as the stock lost 9.17% to a closing price of $4.46. The stock saw 749,979 shares trade hands over the course of the


Genocea Biosciences Inc. (GNCA) Drops 9.17% on October 04

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) was one of the Russell 2000's biggest losers for Tuesday October 04 as the stock slid 9.17% to $4.46, a loss of $-0.45 per share. Starting at an opening price of


Genocea Biosciences Inc. (GNCA) is Trading Lower on Unusual Volume for October 03

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) experienced unusually high volume on Oct. 03, as the stock lost 4.1% to a closing price of $4.91. The stock saw 735,576 shares trade hands over the course of the


Genocea Biosciences Inc. (GNCA) is Trading Lower on Unusual Volume for September 29

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) experienced unusually high volume on Sep. 29, as the stock lost 11.54% to a closing price of $5.06. The stock saw 5.31 million shares trade hands over the course of


Genocea Biosciences Inc. (GNCA) Drops 11.54% on September 29

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) was one of the Russell 2000's biggest losers for Thursday September 29 as the stock slid 11.54% to $5.06, a loss of $-0.66 per share. Starting at an opening price


Genocea Biosciences Inc. (GNCA) is Trading Higher on Unusual Volume for September 27

Equities Staff | Equities.com |

Genocea Biosciences Inc. (GNCA) experienced unusually high volume on Sep. 27, as the stock gained 3.07% to a closing price of $5.71. The stock saw 421,672 shares trade hands over the course of the


World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019


Events

Sohn Investment Conference

Wall Street’s best and brightest investors participate in this unique, “must attend” event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset…

Learn more